3D Global Biotech Inc.(TW:6808)
NT$26.10+0.10 (+0.38%)
TW:6808
3D Global Biotech Inc. financials statements
NT$26.10
At close:+0.10 (+0.38%)
3D Global Biotech Inc. (6808) Financial Statements
3D Global Biotech Inc. Financial Overview
3D Global Biotech Inc.'s market cap is currently NT$2.00B. The company's EPS TTM is NT$0.19; its P/E ratio is 137.89; and it has a dividend yield of 0.51%. 3D Global Biotech Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 206.74M | NT$ 265.69M | NT$ 20.63M | NT$ 13.64M | NT$ 11.07M |
| Gross Profit | NT$ 127.50M | NT$ 174.51M | NT$ 5.27M | NT$ 2.72M | NT$ 1.80M |
| Operating Income | NT$ 41.45M | NT$ 88.70M | NT$ -62.85M | NT$ -66.29M | NT$ -62.21M |
| EBITDA | NT$ 69.10M | NT$ 118.02M | NT$ -35.85M | NT$ -57.02M | NT$ -35.82M |
| Net Income | NT$ 66.53M | NT$ 91.70M | NT$ -57.95M | NT$ -67.09M | NT$ -59.70M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 477.25M | NT$ 703.86M | NT$ 166.02M | NT$ 208.43M | NT$ 233.17M |
| Total Assets | NT$ 1.09B | NT$ 1.04B | NT$ 324.15M | NT$ 371.26M | NT$ 424.51M |
| Total Debt | NT$ 48.66M | NT$ 84.76M | NT$ 10.38M | NT$ 16.75M | NT$ 21.31M |
| Net Debt | NT$ 31.21M | NT$ 28.64M | NT$ -11.44M | NT$ 1.22M | NT$ 935.00K |
| Total Liabilities | NT$ 106.12M | NT$ 132.88M | NT$ 30.68M | NT$ 30.66M | NT$ 34.81M |
| Stockholders' Equity | NT$ 984.53M | NT$ 904.69M | NT$ 293.47M | NT$ 340.60M | NT$ 389.71M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 104.60M | NT$ 14.74M | NT$ -32.39M | NT$ -35.34M | NT$ -38.87M |
| Operating Cash Flow | NT$ 110.91M | NT$ 19.65M | NT$ -31.61M | NT$ -34.49M | NT$ -35.99M |
| Investing Cash Flow | NT$ -55.01M | NT$ -494.50M | NT$ 33.58M | NT$ 18.20M | NT$ 52.29M |
| Financing Cash Flow | NT$ -94.57M | NT$ 509.15M | NT$ 4.32M | NT$ 11.45M | NT$ -4.36M |
Currency in TWD

